ICICI Bank Limited bought 29,015,693 ICICI Prudential Life insurance shares, representing approximately 2.00% of the insurer’s equity, for about ₹14.70 billion. The purchase takes ICICI Bank’s holding in ICICI Life to approximately 52.8%, giving investors a clear update on the bank’s ownership position in its subsidiary.
Key Highlights
- ICICI Bank paid approximately ₹14.70 billion for the ICICI Life share purchase.
- Each purchased ICICI Life Equity share had a Face Value of ₹10.
- ICICI Bank completed its purchase of additional equity shares in ICICI Prudential Life Insurance Company Limited.
₹14.70 Billion Purchase Completed
The transaction takes ICICI Bank (NYSE: IBN)’s holding in ICICI Life to approximately 52.8%. Each equity share carried a face value of ₹10. The purchase fulfilled the bank’s stated Acquisition of additional shareholding of up to 2% in ICICI Life. ICICI Bank identified June 30, 2026 as the date for the equity-capital basis used in calculating the approximately 2.00% representation.
ICICI Bank Holding Reaches 52.8%
The completed purchase leaves ICICI Bank with approximately 52.8% of ICICI Life. The bank had previously referred to the transaction in disclosures dated February 28, 2026 and June 24, 2026.
FAQs
Q: How many ICICI Life shares did ICICI Bank buy?
A: ICICI Bank completed its purchase of additional equity shares in ICICI Prudential Life Insurance Company Limited. The acquisition represented approximately 2.00% and fulfilled the bank’s stated purchase of additional shareholding of up to 2%.
Q: How much did ICICI Bank pay for the ICICI Life stake?
A: ICICI Bank paid approximately ₹14.70 billion for the additional ICICI Life shareholding. The purchases were executed through the stock exchange mechanism.
Q: What is ICICI Bank’s stake in ICICI Life now?
A: ICICI Bank’s shareholding in ICICI Life stands at approximately 52.8% after the completed purchase. The transactions were executed in multiple tranches through September 2, 2026.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.